Moreover, FMOD is overexpressed in multiple cancers, including lung cancer, prostate cancer, and chronic lymphocytic leukemia, and is a potential biomarker for B-cell acute lymphoblastic leukemia [19,20,21]. The gene discussed is FMOD; the disease is cancer.